Philogen SpA

Philochem AG Announces the Licensing of Worldwide Rights to OncoACP3, a novel Radiopharmaceutical Therapeutic and Diagnostic Agent targeting Prostate Cancer, to RayzeBio, a Bristol-Myers Squibb Company, for a potential value of up to $1.35bn plus royalties

10 июн 2025 14:55:14 Источник Nasdaq GlobeNewswire

Philogen provides update on pre-planned interim analysis of the Phase III FIBROSARC trial investigating Onfekafusp alfa (L19TNF) in patients with first-line advanced or metastatic Soft Tissue Sarcoma

19 фев 2024 22:30:00 Источник Nasdaq GlobeNewswire

Philogen S.p.A. announces receipt of the Good Manufacturing Practice Certificate for its new Production facility in Rosia (Siena, Italy) by Competent Authorities

04 дек 2023 23:30:00 Источник Nasdaq GlobeNewswire

Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors

04 дек 2023 00:00:00 Источник Nasdaq GlobeNewswire

Nidlegy™ Phase III PIVOTAL trial meets the study’s primary objective demonstrating statistically significant and clinically meaningful improvement in Recurrence-Free Survival for patients with locally advanced fully resectable melanoma

16 окт 2023 05:21:36 Источник Nasdaq GlobeNewswire

Philogen Announces Clinical Trial Collaboration with MSD

31 май 2023 23:30:00 Источник Nasdaq GlobeNewswire

Sun Pharma and Philogen enter into an Exclusive Distribution, License, and Supply Agreement for Commercializing specialty product, NIDLEGY™ in Europe, Australia and New Zealand

29 май 2023 22:00:00 Источник Nasdaq GlobeNewswire

Philogen Publishes New Data on a Fibromun-based treatment combination in Science Translational Medicine in collaboration with the University Hospital Zürich

24 май 2023 23:00:00 Источник Nasdaq GlobeNewswire

Philogen Announces Publication of a New Study in Collaboration with Google focused on Machine Learning models applied to DNA-Encoded Chemical Library Technology

27 мар 2023 23:00:00 Источник Nasdaq GlobeNewswire

Philogen Provides Corporate Update

30 ноя 2022 23:00:00 Источник Nasdaq GlobeNewswire

Philogen Provides Corporate Update

23 июн 2022 00:00:00 Источник Nasdaq GlobeNewswire

Philochem and Bracco Imaging Announce a Collaboration on the Development of a Small Molecule for Diagnostic or Medical Imaging Applications

22 мар 2022 00:05:00 Источник Nasdaq GlobeNewswire

Philogen announces publication of PET clinical data with proprietary ultra-high affinity FAP-targeting small molecule ligand (OncoFAP)

06 янв 2022 23:00:00 Источник Nasdaq GlobeNewswire

PHILOGEN ANNOUNCES NEW COLLABORATION WITH JANSSEN TO DISCOVER SMALL MOLECULE THERAPEUTICS

24 ноя 2021 00:00:00 Источник Nasdaq GlobeNewswire

Philogen Provides Corporate Update

11 ноя 2021 23:00:00 Источник Nasdaq GlobeNewswire

Philogen Provides Corporate Update

29 сен 2021 01:58:35 Источник Nasdaq GlobeNewswire

Philogen Announces R&D Program Update

01 июл 2021 23:00:00 Источник Nasdaq GlobeNewswire

Philogen Announces First Quarter 2021 Results and Provides Update on Pipeline Progress

12 май 2021 10:00:00 Источник Nasdaq GlobeNewswire